Mole-Check App vs Dermatologist: When Each One Is Worth It
When you spot a mole that worries you, you have two broad choices: open an app or book a dermatologist. They are not really competitors - one is instant and cheap or free, the other is definitive but slower and costlier. The smart move is knowing which job each does well, so you neither pay for an appointment you did not need nor lean on an app when a spot genuinely requires an exam. Here is the honest breakdown.
What an app can and cannot do
Mole-check apps and web tools do triage. AI apps analyse a photo and rate risk; criteria-based web checkers apply the ABCDE rule to your answers. Both are instant, cheap or free, and private to varying degrees.
What none of them can do is diagnose. They cannot feel a lesion, use a dermatoscope to see beneath the surface, assess your history and risk factors, or take a biopsy. They are a first filter, not an answer.
What a dermatologist does that no app can
A dermatologist examines the spot with a dermatoscope, revealing pigment patterns and structures invisible to the naked eye or a phone camera. They factor in your family history, skin type, and how the lesion has evolved, compare it against your other moles in person, and - critically - can biopsy anything uncertain. A biopsy is the only definitive diagnosis of skin cancer.
That is why an expert exam with dermoscopy catches melanomas that photo apps miss, and why it is the standard for anything genuinely suspicious.
Cost and speed
Apps: instant, and free to roughly $50/year. Dermatologist: slower to access and more expensive - in the US, an out-of-pocket consult often runs $100-200+, more if a biopsy or removal is needed, though insurance or public health systems change this picture enormously by country.
The practical implication: use the free/cheap instant layer to decide whether the slower, costlier, definitive layer is warranted. That sequencing saves both unnecessary appointments and dangerous delays.
When to skip the app and see a dermatologist now
Go straight to a dermatologist - do not rely on an app - if a mole is changing in size, shape, or colour; looks different from all your others; has an irregular border or multiple colours; is larger than 6mm; itches, bleeds, crusts, or will not heal in four weeks; or is new after age 30. Book sooner if you have a personal or family history of melanoma.
In these cases the app has already done its job by flagging concern; the next step is the exam, not another scan.
The best workflow: use both, in order
The most sensible approach is layered. Use a free tool to screen a spot in seconds. If it looks ordinary and is not changing, monitor it with monthly self-checks and photos. If it scores, is changing, or simply keeps worrying you, book the dermatologist - and report exactly what changed.
That way the app handles the 95% of spots that are fine and routes the important 5% to the person who can actually diagnose them.
Start with a free 30-second read using our ABCDE checker - if the spot scores, is changing, or worries you, take that straight to a dermatologist for a dermoscopic exam.
Start free ABCDE checkFrequently asked questions
Can a mole-check app replace seeing a dermatologist?
No. Apps triage - they help you decide whether to see a dermatologist. Only a dermatologist with a dermatoscope, and ultimately a biopsy, can diagnose a lesion.
How much cheaper is an app than seeing a dermatologist?
Apps range free to about $50/year; an out-of-pocket dermatologist visit in the US commonly runs $100-200+, more with a biopsy or removal.
When should I skip the app and go straight to a dermatologist?
If a mole is changing, has an irregular border, more than one color, is larger than 6mm, bleeds, won't heal in four weeks, or is new after age 30.
What's the smartest way to use both an app and a dermatologist?
Screen first with a free tool, monitor ordinary spots monthly, and book a dermatologist for anything that scores, changes, or keeps worrying you.
Sources
Content based on clinical guidelines from the American Academy of Dermatology (AAD), British Association of Dermatologists (BAD), and peer-reviewed literature from JAAD, BJD, and JAMA Dermatology. Epidemiological data from NCI SEER and IARC GLOBOCAN. Full methodology